Sector |
|
Compare with Sector peers |
Industry |
|
Compare with Industry peers |
Website | http://www.unichemlabs.com | |
Market Cap | 2,946.48 Cr. | |
Enterprise Value(EV) | 3,157.90 Cr. | 2023-09 |
Financial Indicators | ||
---|---|---|
Earnings per share (EPS) | -18.94 | Trailing Twelve Months Ending 2023-09 |
Price-Earning Ratio (PE) | - | Trailing Twelve Months Ending 2023-09 |
Industry PE | 38.75 | Trailing Twelve Months Ending 2023-09 |
Book Value / Share | 342.02 | Trailing Twelve Months Ending 2023-09 |
Price to Book Value | 1.22 | Calculated using Price: 418.50 |
Dividend Yield | 0.00 | Period Ending 2023-03 |
No. of Shares Subscribed | 7.04 Cr. | 70,405,751 Shares |
FaceValue | 2 | |
About Unichem Laboratories Ltd. | ||
Unichem Laboratories, incorporated in 1962, is engaged in manufacturing formulations, pharmaceuticals and active pharmaceutical ingredients (APIs). The company was promoted by the late Amrut Mody, a pioneer in the Indian pharmaceuticals business. |
1 Day |
|
-0.06% |
1 Week |
|
+2.09% |
1 Month |
|
-4.44% |
3 Month |
|
+0.66% |
6 Month |
|
+12.74% |
1 Year |
|
+2.96% |
2 Year |
|
+99.22% |
5 Year |
|
+105.85% |
10 Year |
|
+121.41% |
9 years | 2015-03 | 2016-03 | 2017-03 | 2018-03 | 2019-03 | 2020-03 | 2021-03 | 2022-03 | 2023-03 | |
Return on Equity (%) | 8.95 | 11.92 | 10.77 | 136.04 | -0.90 | -2.37 | 1.37 | 1.28 | -8.04 | |
Return on Capital Employed (%) | 9.29 | 14.97 | 13.42 | 162.77 | -1.77 | -1.49 | 2.12 | 1.00 | -5.60 | |
Return on Assets (%) | 6.55 | 8.82 | 7.68 | 108.06 | -0.75 | -1.94 | 1.11 | 1.03 | -6.22 |
Particulars | 10 years | 2015-03 Rs. Cr. | 2016-03 Rs. Cr. | 2017-03 Rs. Cr. | 2018-03 Rs. Cr. | 2019-03 Rs. Cr. | 2020-03 Rs. Cr. | 2021-03 Rs. Cr. | 2022-03 Rs. Cr. | 2023-03 Rs. Cr. | 2023-09* Rs. Cr. |
Shh. Funds | 868 | 954 | 1,064 | 2,680 | 2,620 | 2,531 | 2,557 | 2,618 | 2,435 | 2,408 | |
Non Curr. Liab. | 74 | 76 | 64 | 46 | 10 | 44 | 49 | 144 | 108 | 103 | |
Curr. Liab. | 212 | 275 | 393 | 464 | 503 | 567 | 506 | 552 | 640 | 554 | |
Minority Int. | |||||||||||
Equity & Liab. | 1,153 | 1,305 | 1,521 | 3,190 | 3,133 | 3,142 | 3,112 | 3,314 | 3,183 | 3,065 | |
Non Curr. Assets | 589 | 673 | 772 | 854 | 1,094 | 1,455 | 1,734 | 1,666 | 1,591 | 1,529 | |
Curr. Assets | 564 | 632 | 748 | 2,336 | 2,039 | 1,686 | 1,377 | 1,645 | 1,588 | 1,536 | |
Misc. Exp. not W/O | |||||||||||
Total Assets | 1,153 | 1,305 | 1,521 | 3,190 | 3,133 | 3,142 | 3,112 | 3,314 | 3,183 | 3,065 |
Particulars | 10 years | 2015-03 Rs. Cr. | 2016-03 Rs. Cr. | 2017-03 Rs. Cr. | 2018-03 Rs. Cr. | 2019-03 Rs. Cr. | 2020-03 Rs. Cr. | 2021-03 Rs. Cr. | 2022-03 Rs. Cr. | 2023-03 Rs. Cr. | 2023-09 Rs. Cr. TTM |
Net Sales | 1,202 | 1,333 | 1,540 | 1,380 | 1,188 | 1,104 | 1,235 | 1,270 | 1,343 | 1,543 | |
Other Income | 21 | 19 | 6 | 3,278 | 98 | 91 | 50 | 48 | 39 | 36 | |
Total Income | 1,223 | 1,352 | 1,546 | 4,658 | 1,287 | 1,195 | 1,285 | 1,317 | 1,382 | 1,579 | |
Total Expenditure | -1,101 | -1,169 | -1,358 | -1,358 | -1,269 | -1,155 | -1,144 | -1,197 | -1,389 | -1,533 | |
PBIDT | 122 | 183 | 188 | 3,300 | 17 | 40 | 141 | 120 | -7 | 46 | |
Interest | -3 | -3 | -3 | -8 | -8 | -8 | -5 | -6 | -17 | -22 | |
Depreciation | -41 | -39 | -44 | -51 | -67 | -82 | -84 | -91 | -113 | -119 | |
Taxation | -2 | -29 | -33 | -696 | 34 | -12 | -17 | 11 | -26 | -5 | |
Exceptional Items | -4 | -39 | -34 | ||||||||
PAT | 75 | 108 | 108 | 2,545 | -24 | -61 | 35 | 33 | -202 | -133 | |
Minority Interest | |||||||||||
Share Associate | 0 | 0 | 0 | 0 | 0 | 1 | 0 | ||||
Other Related Items | |||||||||||
Consolidated Net Profit | 75 | 108 | 109 | 2,545 | -24 | -60 | 34 | 33 | -202 | -133 | |
Adjusted EPS | 8 | 12 | 12 | 362 | -3 | -9 | 5 | 5 | -29 | -19 |
Particulars | 10 years | 2014-03 Rs. Cr. | 2015-03 Rs. Cr. | 2016-03 Rs. Cr. | 2017-03 Rs. Cr. | 2018-03 Rs. Cr. | 2019-03 Rs. Cr. | 2020-03 Rs. Cr. | 2021-03 Rs. Cr. | 2022-03 Rs. Cr. | 2023-03 Rs. Cr. |
Cash Fr. Operatn. | 87 | 78 | 112 | 68 | -112 | -328 | 20 | 33 | -260 | -85 | |
Cash Fr. Inv. | 36 | -52 | -85 | -128 | 1,648 | -286 | -36 | -74 | 102 | 203 | |
Cash Fr. Finan. | -95 | -51 | -33 | 59 | -881 | -2 | -62 | -121 | 191 | -81 | |
Net Change | 28 | -25 | -7 | 0 | 655 | -616 | -78 | -162 | 34 | 36 | |
Cash & Cash Eqvt | 52 | 27 | 20 | 11 | 666 | 197 | 232 | 77 | 109 | 184 |
Fri, 24 Nov 2023
Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate Intimation of loss of share certificate under Regulation 39(3) of SEBI (Listing Obligations Disclosure Requirement) Regulations 2015. |
Thu, 02 Nov 2023
Announcement under Regulation 30 (LODR)-Newspaper Publication Financial results for the second quarter and six months ended September 30 2023 of the financial year 2023-24 were published in the newspapers on November 2 2023. |
Wed, 01 Nov 2023
Board Meeting Outcome for Outcome Of Board Meeting Held On November 1 2023 We would like to inform you that Board of Directors at its Meeting held today i.e. Wednesday November 1 2023 approved the Unaudited Financial Results (Standalone & Consolidated) for the Second and Six months ended September 30 2023 of the financial year 2023-24. Enclosed herewith please find the Unaudited Financial Results (Standalone & Consolidated) for the second quarter and six months ended September 30 2023 of the financial year 2023-24 and the Auditors Reports thereon. |
Fri, 01 Dec 2023 |
|
|
|
|
|